Sign in

Eton Pharmaceuticals, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.08 0.04 0.03 0.02 0.02 0.00 0.00 0.00 0.00
Cost of revenue 0.04 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit 0.04 0.02 0.02 0.01 0.02 0.00 0.00 0.00 0.00
Total operating expenses + 0.04 0.03 0.02 0.02 0.02 0.03 0.02 0.01 0.01
Operating income 0.00 0.00 0.00 -0.01 0.00 -0.03 -0.02 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax 0.00 0.00 0.00 -0.01 0.00 -0.03 -0.02 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income 0.00 0.00 0.00 -0.01 0.00 -0.03 -0.02 -0.01 -0.01
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17
Total revenue 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Operating income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 -0.01 0.00 0.01 -0.01 -0.01 0.00 -0.01 0.00 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 -0.01 0.00 0.01 -0.01 -0.01 0.00 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 -0.01 0.00 0.01 -0.01 -0.01 0.00 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 0.03 0.01 0.02 0.02 0.01 0.02 0.01 0.03 0.01
Accounts receivable, net 0.01 0.01 0.00 0.00 0.01 0.00 0.00
Inventories 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.06 0.04 0.03 0.02 0.02 0.02 0.02 0.03 0.01
Total non-current assets + 0.03 0.04 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Total assets 0.09 0.08 0.03 0.03 0.03 0.03 0.02 0.03 0.01
Total current liabilities + 0.04 0.02 0.02 0.01 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.03 0.03 0.00 0.01 0.01 0.01 0.00 0.00 0.00
Total liabilities 0.07 0.05 0.02 0.01 0.01 0.01 0.01 0.00 0.00
Total stockholders' equity + 0.03 0.02 0.02 0.01 0.02 0.02 0.01 0.03 0.01
Common shares outstanding 27 26 26 25 25 21 18 6 17
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17
Total cash and short-term investments + 0.02 0.03 0.04 0.03 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.02 0.01 0.02 0.03 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.03 0.01 0.01 0.01 0.01 0.00 0.00
Accounts receivable, net 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.01 0.02 0.02 0.02 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.05 0.06 0.07 0.07 0.05 0.04 0.03 0.03 0.02 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.01 0.01 0.02 0.02 0.01 0.02 0.02 0.03 0.01 0.01 0.01 0.01
Total non-current assets + 0.04 0.03 0.03 0.03 0.03 0.04 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.10 0.09 0.10 0.10 0.08 0.08 0.04 0.03 0.03 0.03 0.03 0.03 0.02 0.03 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.01 0.01 0.02 0.02 0.01 0.02 0.02 0.03 0.01 0.01 0.01 0.01
Total current liabilities + 0.04 0.04 0.04 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.02 0.03 0.04 0.04 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.07 0.07 0.08 0.08 0.06 0.05 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total stockholders' equity + 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.00 0.01 0.01 0.01 0.01 0.02 0.02 0.03 0.00 0.01 0.01 0.01
Common shares outstanding 32 27 27 27 27 26 27 26 26 26 26 26 26 26 25 25 25 26 25 25 27 24 21 21 18 18 18 18 18 12 6 6 6 4 6 3
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + 0.01 0.00 0.01 0.00 0.00 -0.02 -0.02 -0.01 0.00
Cash flow from investing + 0.00 -0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.03 0.00 0.00 0.00 0.03 0.01 0.02 0.02
Change in cash 0.01 -0.01 0.01 0.00 -0.01 0.01 -0.01 0.01 0.01
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17
Operating cash flow + 0.01 -0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 -0.01 -0.01 0.00 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from investing + -0.02 0.00 0.00 -0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.01 0.02
Change in cash -0.01 -0.01 0.01 0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.02 0.02 0.02 0.02 0.01 0.00 0.02
5 days ago

Eton Pharmaceuticals, Inc. (ETON) - Shares Outstanding Diluted

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Dividend Payout

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Net Income

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Stock Based Compensation

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Cashflow From Financing

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Cashflow From Investment

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Change In Inventory

1Y 2Y 5Y Max
10 days ago

Eton Pharmaceuticals, Inc. (ETON) - Capital Expenditures

1Y 2Y 5Y Max
10 days ago